Research Area: Metabolic Disease
Biological Activity:
Miglitol (Glyset) is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to breakdown complex carbohydrates into glucose. Miglitol (Glyset) is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body. [1]References on Miglitol (Glyset)[1] http://en.wikipedia.org/wiki/Miglitol, , |